samedan logo

 
 
spacer
home > pmps > winter 2001 > wip versus cip - the pros and cons of two cleaning philosophies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

WiP Versus CiP - The Pros and Cons of Two Cleaning Philosophies

WiP or CiP? Clean or pure? Only the user can decide which system best suits their needs. A comparison of the two cleaning philosophies reveals that it is possible to exploit the advantages of the WiP method without sacrificing either cleanliness or safety.

In principle, however, washing the compression compartment of tablet presses represents a significant increase in the level of automation when changing products. This is particularly true where hazardous or extremely dusty granulates are being pressed. Difficulties created in the working area are significantly reduced, and the materials handling process is greatly simplified.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
By Jörg Petersen and Hans-Joachim Pierags of Wilhelm Fette GmbH, Germany
spacer
Jörg Petersen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs

Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine to help address public health needs Sanofi will provide BioNTech access to its state-of-the-art production infrastructure From summer 2021, Sanofi will perform late-stage manufacturing to supply over 125 million doses of COVID-19 vaccine for the European Union This agreement between the two Companies reflects the shared commitment to increase vaccine accessibility
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement